Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients
- PMID: 1546192
- DOI: 10.1016/0167-8140(92)90339-v
Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients
Abstract
A total of 659 freshly diagnosed nasopharyngeal carcinoma (NPC) (1984-1987), were investigated by computed tomography (CT), treated with locoregional radiotherapy to radical dose, and given neoadjuvant chemotherapy (CHEMO) with 2-3 courses of cisplatinum and 5-fluorouracil for bulky (greater than or equal to 4 cm) cervical nodal metastasis and booster radiotherapy (PPB) for parapharyngeal disease. All except 15 patients were fully evaluable with complete data entry till death or to the last follow-up (minimum 2 years). The data have been analysed extensively to identify variables of potential prognostic significance. The assessed factors include patients' sex and age, nasal involvement (NAS), oropharyngeal involvement (ORO), parapharyngeal involvement (PAR), muscle involvement (MU), skull base involvement (BS), cranial nerves (II-VIII) palsy (CN1), cranial nerves (IX-XII) palsy (CN2), intracranial extension (IC), laryngopharyngeal extension (HYP), confinement to nasopharynx (NP), Ho's N-stage (Nho), maximal nodal size (Nmax), nodal mobility (Nf- fixed, Npf- doubt in mobility, Nm- mobile), nodal laterality (unilateral, contralateral, bilateral), nodal multiplicity (single, multiple), and presentation with distant metastasis (M1). These factors have been assessed as to their interdependence and correlation with the clinical course (study endpoints) using both monovariate analyses and Cox's Regression model. Significant association among Ho's T2 and T3 features was identified. Advanced Ho's N-stage correlated significantly with bulky nodes, multiple nodes, fixed nodes, and, contralateral and bilateral nodes. Poor prognostic factors found to be significant by both monovariate analyses and Cox's Regression model included the M1, Nho (advanced), CN1, BS, and CN2 for the actuarial survival (ASR) for all patients (659), the Nho (advanced), CN1, CN2, and BS for the ASR for the non-metastatic patients (628), the absence of NP and the male sex for the local failure rate (628), the Nho (advanced), CN2, and BS for the distant metastasis rate (628), and the Nho (advanced), CN1, and BS for the disease-free survival (DFS) (628). In addition, old age, male sex, and the presence of parapharyngeal disease were probably significant in predicting poor survival (ASR); CN1 was probably significant in predicting more local failures, and, the parapharyngeal disease and the intracranial extension for more distant metastases. The Ho's N-staging is superior to the other N-stage classifications, because once the Ho's N-stage has been determined, other nodal characteristics including nodal size, multiplicity, laterality, and fixity, are prognostically insignificant.
Comment in
-
Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients by Teo et al.Radiother Oncol. 1992 Nov;25(3):216-7. doi: 10.1016/0167-8140(92)90272-v. Radiother Oncol. 1992. PMID: 1470699 No abstract available.
Similar articles
-
Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):261-71. doi: 10.1016/s0360-3016(98)00383-6. Int J Radiat Oncol Biol Phys. 1999. PMID: 10030248 Clinical Trial.
-
Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):291-304. doi: 10.1016/s0360-3016(96)00323-9. Int J Radiat Oncol Biol Phys. 1996. PMID: 8892451
-
A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).Eur J Cancer B Oral Oncol. 1995 Nov;31B(6):373-9. doi: 10.1016/0964-1955(95)00026-7. Eur J Cancer B Oral Oncol. 1995. PMID: 8746267
-
A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma.Radiother Oncol. 1991 May;21(1):11-23. doi: 10.1016/0167-8140(91)90336-f. Radiother Oncol. 1991. PMID: 1852915 Review.
-
How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):897-913. doi: 10.1016/s0360-3016(97)00854-7. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531376 Review.
Cited by
-
A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.Eur J Nucl Med. 1997 Jun;24(6):621-8. doi: 10.1007/BF00841399. Eur J Nucl Med. 1997. PMID: 9169568
-
Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. doi: 10.1007/s00259-004-1719-2. Epub 2004 Dec 30. Eur J Nucl Med Mol Imaging. 2005. PMID: 15625603 Clinical Trial.
-
EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel.Oncol Lett. 2012 Sep;4(3):429-434. doi: 10.3892/ol.2012.746. Epub 2012 Jun 8. Oncol Lett. 2012. PMID: 23741245 Free PMC article.
-
A novel N staging system for NPC based on IMRT and RTOG guidelines for lymph node levels: Results of a prospective multicentric clinical study.Oncol Lett. 2018 Jul;16(1):308-316. doi: 10.3892/ol.2018.8676. Epub 2018 May 9. Oncol Lett. 2018. PMID: 29928416 Free PMC article.
-
3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.Radiat Oncol. 2010 Nov 23;5:113. doi: 10.1186/1748-717X-5-113. Radiat Oncol. 2010. PMID: 21092297 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous